Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | +0.69% | -5.07% | +2.65% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.65% | 399M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.26% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- UBS Adjusts C4 Therapeutics Price Target to $26 From $64, Maintains Buy Rating